Background and purpose
Moyamoya disease (MMD) is a progressive cerebrovascular disease with unknown etiology. Growing evidence suggest its involvement of autoimmune and genetic mechanisms in the pathogenesis of MMD. This study aims to clarify the association between
HLA
allele and MMD.
Methods
Case-control study: the DNA of 136 MMD patients in Japan was extracted and the genotype of
human leukocyte antigen
(
HLA
) from this DNA was determined by super-high-resolution single-molecule sequence-based typing using next-generation sequencing. Next, the frequency of each
HLA
allele (
HLA-A
,
HLA-B
,
HLA-C
,
HLA-DRB1
,
HLA-DQB1
, and
HLA-DPB1
) was compared with those in the Japanese control database. In addition, haplotype estimation was performed using the expectation maximization algorithm.
Results
The frequencies of the
HLA-DRB1*04
:
10
allele (4.77% vs. 1.47% in the control group;
P
= 1.7 × 10
−3
; odds ratio [OR] = 3.35) and of the
HLA-DRB1*04
:
10–HLA-DQB1*04
:
02
haplotype (haplotype frequency 4.41% vs. 1.35% in the control group;
P
= 2.0 × 10
−3
; OR = 3.37) significantly increased. The frequency of thyroid diseases, such as Graves’ disease and Hashimoto thyroiditis, increased in
HLA-DRB1*04
:
10
-positive MMD patients compared with that in
HLA-DRB1*04
:
10
-negative MMD patients.
Conclusions
HLA-DRB1*04
:
10
is a risk allele and
HLA-DRB1*04
:
10–HLA-DQB1*04
:
02
a risk haplotype for MMD. In addition,
HLA-DRB1*04
:
10
is associated with thyroid disease in MMD patients.